Jeremy Abbate
VP & Publisher
Scientific American
Ryutaro Adachi
Director, Corporate Venture Investment
Eisai Co. Ltd.
Carolina Aguilar
CEO
INBRAIN Neuroelectronics
Jarrad Aguirre
Miga Health
Martin Akerman
CTO and Co-Founder
Ensivagenics
Jim Anthony
EVP and Global Head
Parexel Biotech
Drew Armstrong
Executive Editor
Endpoints News
Derk Arts
Founder & CEO
Castor
Ramin Baghirzade
Senior Director, Global Head Commercial, Gene Therapy CDMO Services
Charles River
Anne Bailey
Director, Clinical Tech Innovation
U.S. Department of Veterans Affairs
Kristin Baker Spohn
General Partner
CRV
Dawn Bell
Global Development Head, Strategic Partnerships Team
BIOME by Novartis
Stacy Blain
Concarlo Therapeutic
Katie Bodner Spielberg
Associate
5AM Ventures
Travis Bond
Altoida, Inc.
Steve Brozak
President
WBB Securities LLC
Stephen Bruso
Investor
Morning Side Ventures
Tom Burns
Senior VP, Finance and CFO
XOMA
Jay Campbell
Managing Director, Clinical Accelerator & Venture Fund
Cancer Research Institute
Carin Canale-Theakston
CEO & Founder
Evoke Canale
Melissa Carpenter
Chief Scientific Officer, Regenerative Medicine
ElevateBio
James Cavuoto
Editor & Publisher
Neurotech Reports
Hemmie Chang
Partner, Co-Chair, Life Sciences Group; Chair, Licensing & Strategic Alliances Practice
Foley Hoag
Akshay Chellappa
Director, Corporate Development
Gilead
Adrien Châtillon
Actipulse Neuroscience
Erik Clausen
Managing Partner
CG Life
Grace Colon
Former CEO
InCarda Therapeutics
Jeremy Curnock Cook
Bioscience Managers
Allison DeAngelis
Biotech Startups & Venture Capital Reporter
STAT News
Neel Desai
Senior Director, Business Development & Licensing
Biogen
Stuart Dignam
MTP Connect
Daniel Dornbusch
Excision BioTherapeutics
Imran Eba
Partner
Action Potential Venture Capital
Stacy Feld
Regional Head, West North America, Australia & New Zealand
Johnson & Johnson Innovation
Simone Fishburn
VP and Editor-in-Chief
BioCentury
Aaron Gani
BehaVR
Jennifer Garrison
Co-Founder & Director, Global Consortium for Reproductive Longevity & Equality and Assistant Professor
Buck Institute
Chris Ghadban
Chief of Staff
Alix Ventures
Michael Goldberg
Surge Therapeutics
Walter Greenleaf
Distinguished Visiting Scholar
Stanford University’s MediaX Program
Kimberly Ha
CEO and Founder
KKH Advisors
Alex Harding
Head of Business Development
CRISPR Therapeutics
Charlie Hartwell
Managing Director
Bridge Builders Collaborative
Paul Hastings
President and CEO
Nkarta Therapeutics
Jim Healy
Sofinnova
Derek Hicks
Chief Business Officer
Intellia Therapeutics
William Ho
Founder, President and CEO
IN8bio
Beth Hoffman
Origami Therapeutics
Chihiro Hosoya
Head of Venture Management and Business Development
Astellas Rx+ Business Accelerator
Kevin Huh
Korea Innovative Medicines Consortium
Tim Hunt
Alliance for Regenerative Medicine
Mandy Jackson
Managing Editor, US Commercial News
Scrip/The Pink Sheet
Abigail Jenkins
President & CEO
Gamida Cell
Darren Ji
Co-Founder, CEO
Elpiscience
Hyun-Bae Jie
CEO and Chief Technology Officer
Levatio Therapeutics
Ben Johnson
Head of Early Stage
Silicon Valley Bank
Allison Johnston
Vice President, Life Science & Healthcare
Matt Kapusta
uniQure
Elizabeth Kelly
Principal
Pappas Capital
Edward Kliphuis
Sofinnova Partners
Shigeru Kobayashi
Chairman, President & CEO
Chiome Bioscience Inc.
Ekaterine Kortkhonjia
Senior Director, Early Innovation Partnering
Suma Krishnan
Founder and COO
Krystal Biotech
Vivian Lee
Aqua Partners LLC
Amy Leiser
Covington
Chandra Leo
HBM Partners
Ron Leuty
Senior Reporter
San Francisco Business Times
Jeremy Levin
Chairman and CEO
Ovid Therapeutics
Zili Li
Vice President, Head of Asia Pacific Division
Janssen Research & Development
Helen Liang
Founder & Managing Partner
FoundersX Ventures
Han Lim
CBO
DeepCure
Angus Liu
Senior Staff Writer
Fierce Pharma
Yuwen Liu
Founding Partner
Bohe Angel Fund
Philippe Lopes-Fernandes
Executive VP and CBO
Ipsen
Michael Ludwig
MTS Health Partners
Michael Luther
Global Head Search & Evaluation, Business Development
Astellas Pharma
Crystal Mackall
Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine
Stanford University
Eddie Martucci
Founder and CEO
Akili Interactive Labs
Owen McCarthy
MedRhythms
Martina Molsbergen
C14 Consulting Group LLC
Dave Moore
Senior Vice President, Corporate Development
Novo Nordisk
Aziz Mottiwala
CCO
Tarsus Pharmaceuticals
Lorenz Muller
Chief Commercial Officer
Milestone Pharmaceuticals
Ann Murray
Global Senior Director, Business Development
Charles River Labs
Jeff Myers
Medicaid Health Plans of America
Matthias Müllenbeck
Director, Licensing & Business Development
EMD Serono
Marian Nakada
VP, Venture Investments
Johnson & Johnson Innovation, JJDC
Daniel Oliver
Rejuvenate Bio
Tim Opler
Partner & Co-Founder
Torreya
Art Pappas
CEO and Managing Partner
Ali Pashazadeh
Founder
Treehill Partners
Neel Patel
Executive Managing Director, Head Commercial Advisory Group - Consulting
Syneos Health Consulting
Victor Pikov
Medipace
Maria Pineda
Co-Founder and CEO
Envisagenics
Cristiana Principato
Senior Data Scientist
Compass Pathways
Linda Pullan
Business Development Consultant
Pullan Consulting
Sachin Purwar
Managing Director, Commercial Advisory Group
Syneos Health
Deborah Rathjen
Carina Biotech
Adrian Rawcliffe
Adaptimmune Therapeutics
Nanea Reeves
CEO and Co-Founder
TRIPP, Inc.
Lisa Ricciardi
Cognition Therapeutics, Inc.
Beth Rogozinski
Oncoustics
Brian Rosenzweig
Covington & Burling LLP
Lex Rovner
64x Bio
Peter Rubin
Executive Director
No Patient Left Behind
Zaki Salanti
Senior Director, Head of Search & Evaluation
Novo Nordisk A/S
Regina Salvat
Sofinnova Investments
Jodi Scott
Hogan Lovells US LLP
Bruce Seeley
Former COO
CTI BioPharma
Jaisim Shah
CEO & President
Scilex
Barbara Alcaraz Silva
Director, Early Stage Life Science West Coast
Daniel-Adriano Silva
Monod Bio
Brad Sitko
Chief Investment Officer
Devyn Smith
Arbor Biotechnologies
Andrew Strong
Hogan Lovells
David Suendermann-Oeft
Modality.AI, Inc.
Sze-Wee Tan
Assistant Chief Executive
Innovation & Enterprise Group, Agency for Science & Technology Research (A*STAR)
Lee Taurman
Executive Vice President, Global Head, Syneos One®
Pascal Touchon
Atara Biotherapeutics
Alice Valder Curran
John Vandermosten
Senior Biotechnology Analyst
Zacks Investment Research
Brent Vaughan
Cognito Therapeutics
Uma Verma
Senior Director, Business Development
Kulika Weizman
, Principal
Creative Ventures
James Williams
Head of Biogen Digital Health Ventures
Richard Wilson
Senior VP, Primary Focus Lead Genetic Regulation
Gwendolyn Wu
Reporter
BioPharma Dive
Peter Young
Venture Partner
Hanadie Yousef
Juvena Therapeutics
Alice Zheng
RH Capital